"Gene Rearrangement" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ordered rearrangement of gene regions by DNA recombination such as that which occurs normally during development.
| Descriptor ID |
D015321
|
| MeSH Number(s) |
G05.344
|
| Concept/Terms |
Gene Rearrangement- Gene Rearrangement
- Gene Rearrangements
- Rearrangement, Gene
- Rearrangements, Gene
- DNA Rearrangement
- DNA Rearrangements
- Rearrangement, DNA
- Rearrangements, DNA
|
Below are MeSH descriptors whose meaning is more general than "Gene Rearrangement".
Below are MeSH descriptors whose meaning is more specific than "Gene Rearrangement".
This graph shows the total number of publications written about "Gene Rearrangement" by people in this website by year, and whether "Gene Rearrangement" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 3 | 4 |
| 1996 | 1 | 7 | 8 |
| 1997 | 2 | 5 | 7 |
| 1998 | 2 | 7 | 9 |
| 1999 | 3 | 6 | 9 |
| 2000 | 1 | 3 | 4 |
| 2001 | 3 | 2 | 5 |
| 2002 | 5 | 5 | 10 |
| 2003 | 1 | 4 | 5 |
| 2004 | 1 | 4 | 5 |
| 2005 | 3 | 7 | 10 |
| 2006 | 5 | 4 | 9 |
| 2007 | 4 | 6 | 10 |
| 2008 | 8 | 3 | 11 |
| 2009 | 10 | 9 | 19 |
| 2010 | 8 | 6 | 14 |
| 2011 | 9 | 8 | 17 |
| 2012 | 15 | 10 | 25 |
| 2013 | 3 | 8 | 11 |
| 2014 | 3 | 5 | 8 |
| 2015 | 4 | 16 | 20 |
| 2016 | 4 | 9 | 13 |
| 2017 | 3 | 14 | 17 |
| 2018 | 5 | 5 | 10 |
| 2019 | 11 | 8 | 19 |
| 2020 | 5 | 9 | 14 |
| 2021 | 5 | 11 | 16 |
| 2022 | 0 | 7 | 7 |
| 2023 | 1 | 5 | 6 |
| 2024 | 2 | 7 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gene Rearrangement" by people in Profiles.
-
Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement. Am J Clin Pathol. 2024 Nov 04; 162(5):455-463.
-
Long-read sequencing of an advanced cancer cohort resolves rearrangements, unravels haplotypes, and reveals methylation landscapes. Cell Genom. 2024 Nov 13; 4(11):100674.
-
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk. Cancer Discov. 2024 Oct 04; 14(10):1838-1859.
-
Selective inhibition of HDAC class IIA as therapeutic intervention for KMT2A-rearranged acute lymphoblastic leukemia. Commun Biol. 2024 Oct 04; 7(1):1257.
-
Myoepithelial tumors of soft tissue and bone in children and young adults: A clinicopathologic study of 40 cases occurring in patients = 21?Years of age. Hum Pathol. 2024 07; 149:10-20.
-
Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia. Int J Hematol. 2024 Aug; 120(2):203-211.
-
Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in KMT2A-rearranged, therapy-related acute lymphoblastic leukemia. Pediatr Blood Cancer. 2024 Jun; 71(6):e30964.
-
Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types. Clin Cancer Res. 2024 02 16; 30(4):836-848.
-
Updates on WHO classification for small round cell tumors: Ewing sarcoma vs. everything else. Hum Pathol. 2024 05; 147:101-113.
-
Myeloid lineage switch in KMT2A-rearranged acute lymphoblastic leukemia treated with lymphoid lineagedirected therapies. Haematologica. 2024 01 01; 109(1):293-297.